baber/WOPTO huggingface dataset:
Patent FI-960908-A0 (FI)
Inventor: SCHIEL CHRISTIAN
IPC: D21F3/08
Filed: 1996-02-27
Abstract: A shoe press roll for a paper machine which, together with a backing roll, forms a press nip through which a press jacket guided over the shoe press roll travels together with a paper web. The shoe press roll comprises a press shoe which can be pressed by at least one hydraulic element against the backing roll. The hydraulic element is developed as a cylinder/piston unit that acts between a stationary support member and the press shoe. The unit includes a first pressure chamber which can be acted on by hydraulic pressure and is in communication via a small diameter throttle point passing through the piston with a second pressure chamber which is open toward the press shoe. The edge of the piston rests with a sealing surface against the press shoe. Hydraulic pressure is transmitted from the first pressure chamber under approximately static conditions, to the second pressure chamber through the throttle point and thus to the press shoe. Should the press shoe tilt permitting pressure to escape from the second chamber at the shoe, the throttle point prevents rapid continuous flow of hydraulic pressure out of the first pressure chamber. The tilting produces a pressure drop in the second pressure chamber which causes the press shoe to apply itself against the cylinder/piston unit as a result of the external pressure applied from the first pressure chamber.
Patent FI-961863-A0 (FI)
Inventor: BAUER BRIGITTE
IPC: A61K38/00
Filed: 1996-05-02
Abstract: PCT No. PCT/SE95/00972 Sec. 371 Date Sep. 12, 1995 Sec. 102(e) Date Sep. 12, 1995 PCT Filed Aug. 30, 1995 PCT Pub. No. WO96/07400 PCT Pub. Date Mar. 14, 1996The invention is directed to a pharmaceutical composition which is a combination of the ACE inhibitor ramipril and a calcium antagonist of one of the dihydropyridine type compounds felodipine, nitrendipine, nifedipine and lacidipine. The pharmaceutical composition is for use in the therapy and treatment of hypertension.
Patent FI-963130-A0 (FI)
Inventor: JEPPESEN LONE
IPC: A61P25/00
Filed: 1996-08-09
Abstract: Imidazo[1,2-a]quinoxalinone derivatives of the general formula   <IMAGE>   wherein R1, R2, R3 are the same or independently are H, alkyl, alkoxy, halogen, NO2, NH2, CF3, CN, SO2CH3, SO2CF3, SO2NR'R'' or a 5- or 6-membered N-containing heterocyclic ring, optionally substituted, and R', R'' are independently H or alkyl; and R4 is H or CH2-R6; and R6 is H, halogen, POR'''R'''', NR7R8 or a 5- or 6-membered N-containing heterocyclic ring optionally substituted, and R''', R'''' are independently hydroxy or alkoxy; and   <IMAGE>   R7, R8 are the same or independently are H, or alkyl optionally substituted; and n is 1, 2 or 3; R5 is   <IMAGE>    <IMAGE>   and R9 is OH, alkoxy, H or NR10R11; and R10, R11 are the same or independently are H, NH2 or OH; and X is O or S; and Y is O, S or NH2, and pharmaceutically acceptable salts thereof, have affinity for the AMPA receptors and are antagonists in connection with this type of receptor which makes them useful in the treatment of CNS ailments, especially in the treatment of any of the numerous indications caused by hyperactivity of excitatory amino acids.
Patent FI-963419-A0 (FI)
Inventor: GARNER IAN
IPC: A01K67/027
Filed: 1996-09-02
Abstract: Materials and methods for producing fibrinogen in transgenic non-human mammals are disclosed. DNA segments encoding Aα, Bβ and γ chains of fibrinogen are introduced into the germ line of a non-human mammal, and the mammal or its female progeny produces milk containing fibrinogen expressed from the introduced DNA segments. Non-human mammalian embryos and transgenic non-human mammals carrying DNA segments encoding heterologous fibrinogen polypeptide chains are also disclosed.
Patent FI-970753-A0 (FI)
Inventor: LUTZ GARY PAUL
IPC: C07B61/00
Filed: 1997-02-21
Abstract: This invention relates to a 5 step process for preparing a purified alkali metal salt of 4-sulfophenyl-[(1-oxyalkanoyl)amino]alkanoate in one reaction vessel without isolation of intermediates. The steps are as follows: A) reacting an alkali metal salt of 4-hydroxybenzenesulfonic acid with a C2 to C4 carboxylic anhydride in a solvent to form an alkali metal salt of 4-acyloxybenzenesulfonic acid and a C2 to C4 carboxylic acid. B) adding an [(1-oxyalkanoyl)amino]alkanoic acid and a transesterification catalyst to the reaction product of step A) and heating at a temperature and pressure sufficient to maintain reflux of the solvent and to remove the C2 to C4 carboxylic acid from the reaction vessel to form a reaction mixture containing an alkali metal salt of 4-sulfophenyl-[(1-oxyalkanoyl)amino]alkanoate. C) removing the solvent from the reaction mixture formed in step B). D) mixing the alkali metal salt of 4-sulfophenyl-[(1-oxyalkanoyl)amino]alkanoate product of step C) with acetic acid. E) and finally separating the product from the acetic acid. The purified alkali metal salt of 4-sulfophenyl-[(1-oxyalkanoyl)amino]alkanoate product is useful as a bleach activator in detergents.
Patent FI-973156-A0 (FI)
Inventor: MUELLER BEAT
IPC: C08F216/38
Filed: 1997-07-30
Abstract: The invention relates to a process for the production of moldings, in particular contact lenses, in which a water-soluble crosslinkable polymer is crosslinked in solution, and to moldings, in particular contact lenses, obtainable by this process. The present invention likewise relates to novel crosslinkable polymers comprising units containing a crosslinkable group, units containing an acidic group and/or units containing a basic group which can be employed in the novel process, in particular derivatives of a polyvinyl alcohol having a molecular weight of at least about 2000, and to crosslinked polymers, either homopolymers or copolymers, made from these novel crosslinkable polymers, a process for the preparation of the novel crosslinkable polymers and the homopolymers and copolymers obtainable therefrom, to moldings made from said homopolymers or copolymers, in particular contact lenses made from these homopolymers or copolymers, and to a process for the production of contact lenses using said homopolymers or copolymers.
Patent IL-61333-A0 (IL)
Title: Secondary amines, their preparation and pharmaceutical compositions containing them
IPC: C07C229/38
Filed: 1980-10-23
Abstract: Compounds of formula (III):   <IMAGE> (III)  and esters, amides and pharmaceutically acceptable salts thereof, wherein A1 is hydrogen or methyl; A2 is hydrogen or methyl; and n is 1, 2 or 3 have anti-obesity activity. Methods for their preparation pharmaceutical formulations of the compounds and their use in medicine are described.
Patent IL-63910-A0 (IL)
Title: 4h-3,1-benzoxazine derivatives,their preparation and their use as herbicides
IPC: C07D265/22
Filed: 1981-09-22
Abstract: 4H-3,1-Benzoxazine derivatives of the formula   <IMAGE>   where R1, R2 and Y have the meanings given in the description, and their use for controlling undesired plant growth.
Patent IL-64397-A0 (IL)
Title: Process for the preparation of liposomal medicaments
IPC: A61K9/127
Filed: 1981-11-27
Abstract: Associates of at least one amphiphilic bilayer-forming substance and a solubilizing agent are formed in an aqueous phase. The bilayer-forming substance itself can be a pharmaceutical substance, or pharmaceutical substances and/or pharmaceutical auxiliaries may be added. The equilibrium conditions for the molar ratio of bilayer-forming substance to solubilizing agent in the associates are then changed in the aqueous phase containing the associates, in order to remove solubilizing agent from the associates, so that the associates combine to form liposomes. In particular, the solubilizing agent concentration in the aqueous phase is reduced, for example by dilution with additional aqueous phase. The change is effected at a rate which is sufficiently high for formation of liposomes having a predefined number of double layers. Furthermore, the rate of change in the aqueous phase is kept virtually constant with respect to location and time. The liposomes thereby achieve a predefined, virtually homogeneous size.
Patent IL-83507-A0 (IL)
Title: Color marker for clonings in streptomyces lividans
IPC: C12N1/21
Filed: 1987-08-12
Abstract: Subjection of Streptomyces coelicolor DSM 3030 to total digestion of the complete DNA, cloning into a suitable vector and transformation of Streptomyces lividans result in colonies with an intense crimson colour. Reisolation of the plasmid DNA and cutting with BamHI results in fragments about 3.4 to 9 kb in length, on which the gene crucial for pigment production is located. The latter is suitable as marker, in particular as inactivation marker, in Streptomycetes.
Patent IL-88204-A0 (IL)
Title: Acyl deoxyribonucleoside derivatives and uses thereof
IPC: A61K8/49
Filed: 1988-10-28
Abstract: Use of acyl derivatives of deoxyribonucleosides in manufacture of a medicament for enhancing haematopoesis or enhancing healing of bone marrow. <IMAGE>
Patent IL-88678-A0 (IL)
Title: Partition for a corner shower
IPC: E04H1/12
Filed: 1988-12-13
Abstract: A partition, more particularly for a corner shower, contains two door-elements mounted displaceably in an upper guide-rail. In the vicinity of the entrance, the upper guide-rail is curved like the edge of the tub and is connected to two lateral wall elements which are secured to the room and are flat. The purpose of the invention is to achieve reliable sealing and equally reliable guidance combined with a simple design. It is proposed that the guide-rail be curved over its entire length and comprise curved end-parts behind the flat wall-element. No lower guide-rail is provided. Instead, small narrow guide-elements are located outside the entrance.
Patent IL-93699-A0 (IL)
Title: Floating aquatic plant water treatment system
IPC: C02F3/10
Filed: 1990-03-11
Abstract: A floating aquatic plant water treatment system (31) utilizes a serpentine channel (36) defined by dividing walls (34). Floating plants (72) are distributed across the water surface by a floating grid structure (32). The grid structure (32) is preassembled into Z-fold bundles (88) which are towed onto the water and unfolded. The treatment system uses sprayers (62) to control growth conditions. Porous baffles (46) are placed along portions of the channel (36) to provide intimate contact with a larger portion of the water while allowing free flow.
Patent IL-95480-A0 (IL)
Title: Process for the preparation of cyclic amino acids,and intermediates
IPC: C07C227/10
Filed: 1990-08-23
Abstract: Processes for the preparation of cyclic amino acid derivatives useful in the treatment of cerebral diseases such as epilepsy are disclosed. Novel intermediates useful in processes are also disclosed.
Patent IL-97487-A0 (IL)
Title: Process for the preparation of castanospermine
IPC: C07D493/14
Filed: 1991-03-08
Abstract: Castanospermine (I) is prepared by starting from 5-(t-BOC)amino-5-deoxy-1,2-O-isopropylidene- alpha -D-glucuronolactone. Two additional carbons are added to the starting material using ethyl acetate and a strong base and the resulting cyclic hemiketal is subjected to a series of reductions, with intervening removal of protecting groups, to give the castanospermine. A substituted hydroxypyrrolidinone and a substituted hydroxypyrrolidine serve as intermediates in the process. <CHEM> -
Patent AU-PO816097-A0 (AU)
Title: Combined electrochromic and photovoltaic smart window devices and methods
IPC: G02F1/163
Filed: 1997-07-22
Abstract: A smart window comprising a regenerative photolectrochomic (RPEC) photovoltaic element (108) juxtaposed with an electrochromic (EC) element (110). Microprocessor-based control mechanism (200) connecting the RPEC element to the EC element for controlling the current delivered to and from the EC element. The controller (200) including look-up tables (204 and 206) for determining the safe current to or from the EC element having regard to the amount of charge to be delivered or removed and the charge status of the EC element, the determination of charge status, charge still required and current to be delivered being made frequently to ensure that the current is kept within safe limits while minimizing switching times. New smart windows are also disclosed.
Patent FI-20020892-A0 (FI)
Inventor: MAN HON-WAH
IPC: C07D413/04
Filed: 2002-05-10
Abstract: Cyclopropyl-N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl] -3-oxoisoindoline-4-yl}-carboxamide, or an acid addition salt thereof, for use in treating an autoimmune disease.
Patent IL-101883-A0 (IL)
Title: Antiviral combinations and pharmaceutical compositions containing them
IPC: A61P43/00
Filed: 1992-05-15
Abstract: Combinations comprising a compound of formula (1) <CHEM> or a pharmaceutically acceptable derivative thereof and an inhibitor of HIV replication, pharmacetical formulations thereof and their use in the treatment of HIV infections. <IMAGE>
Patent IL-107056-A0 (IL)
Title: Laminating adhesive compositions for packaging
IPC: C09J131/04
Filed: 1993-09-21
Abstract: An aqueous laminating adhesive composition is disclosed. The composition is adapted to bond difficult-to-adhere substrates. The composition comprises a vinyl ester/acrylic copolymer having a glass transition temperature from about 10  DEG C. to about -45  DEG C. The composition is free from organic cosolvent.
Patent IL-116249-A0 (IL)
Title: Nk-1 receptor antagonists for the treatment of neuronal injury and stroke
IPC: A61K31/46
Filed: 1995-12-04
Abstract: The present invention relates to a method of treating or preventing a disorder selected from stroke, epilepsy, head trauma, spinal cord trauma, ischemic neuronal damage such as cerebral ischemic damage from stroke or vascular occlusion (e.g., during open heart surgery), excitotoxic neuronal damage (e.g., in stroke or epilepsy) and amyotrophic lateral sclerosis in mammals, including humans, using an NK-1 antagonist. It also relates to a method of treating or preventing such disorders in mammals, including humans, using certain quinuclidine derivatives, piperidine derivatives, pyrrolidine derivatives, azanorbornane derivatives, ethylene diamine derivatives and related compounds that are substance P receptor antagonists.
Patent IL-129672-A0 (IL)
Title: Apparatus and process for forming prosthetic socket
IPC: B29C43/36
Filed: 1997-10-29
Abstract: A prosthesis socket casting device includes a base member on which an elongated annular molding bladder is mounted, the bladder peripherally enclosing a generally centrally located casting area and extendable when inflated from the forward side of the base. The bladder is formed of a pliable, air impermeable, relatively non-stretchable sheet material enclosing, in cooperation with the base, an air chamber peripherally surrounding the casting area. The casting area includes an open residual limb receiving end and extends from such end to the base, and an inflation system for the bladder is provided. The casting device may be used in conjunction with a prosthesis suction socket that includes a tension member at its distal end connectable to the base member during a casting procedure. Moldable and settable prosthesis socket or other moldable casting material is placed over the suction socket and is compression molded by the inflated bladder while the casting material cures. During the compression casting procedure, a tension force resulting from the bladder inflation pressure may be applied to the distal end of the suction socket to elongate and distend the distal area of the residual limb against which the casting material is formed under pressure. The bladder is rollable relative to the base member to provide ready access to the tension member connector carried by the base member.
Patent IL-146476-A0 (IL)
Title: Heterocyclic substituted aminoazacycles useful as central nervous system agents
IPC: A61P25/24
Filed: 2000-05-15
Abstract: Heterocyclic substituted aminoazacyclic compounds of the formula (I):Z-R3, wherein Z is a defined aminoazacycle and R3 is a defined heterocycle moiety, pharmaceutical compositions of these compounds, and use of said compositions to control synaptic transmission in mammals.
Patent IL-152378-A0 (IL)
Title: Edg8 receptor, its preparation and use
IPC: A61P35/00
Filed: 2001-04-14
Abstract: The present invention relates to newly identified human EDG8 receptors, polynucleotides encoding this receptor, polypeptides encoded by such polynucleotides, the preparation and the use of such polynucleotides and polypeptides.
Patent IL-156840-A0 (IL)
Title: Penetration inhibiting material
IPC: F41H1/02
Filed: 2002-03-08
Abstract: The invention pertains to a penetration-resistant material comprising at least a double layer of woven fabric, characterized in that the double layer comprises a first layer of fabric composed of a first set of threads comprising 3.5 to 20 threads/cm, having a linear density of at least 210 dtex, and comprising at least 65% of the fabric weight, and a second set of threads comprising 0.5 to 16 threads/cm and having a linear density of at least 50 dtex, with the second set of threads being transverse to the first set of threads, and the ratio of the number of threads/cm of the first set to that of the second set is > 1, and a second layer of fabric composed of a first set of threads comprising 0.5 to 16 threads/cm and having a linear density of at least 50 dtex, and a second set of threads comprising 3.5 to 20 threads/cm, having a linear density of at least 210 dtex, and comprising at least 65% of the fabric weight, with the second set of threads being transverse to the first set of threads, and the ratio of the number of threads/cm of the second set to that of the first set is > 1, and wherein the first and second sets of threads of the first layer have a parallel orientation towards the first and second sets, respectively, of threads of the second layer.
Patent IL-158530-A0 (IL)
Title: Method for producing 1,3-disubstituted 2-nitroguanidines
IPC: C07D277/20
Filed: 2002-04-24
Abstract: The present invention relates to a process for the preparation of compounds of the formula (I) by reacting compounds of the formula (II) in which R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>4 </SUP>and Het are as defined in the description, with anhydrous hydrogen halide in the presence of a nitrile.
Patent IL-178169-A0 (IL)
Title: Coated abrasive products and processes for forming same
IPC: B24D11/00
Filed: 2006-09-18
Abstract: A coated abrasive product is disclosed, which includes a substrate and an abrasive layer overlying the substrate. The abrasive layer includes abrasive grains and a binder, the binder being formed from a binder formulation having first and second binder components mixed together uniformly with the abrasive grains, wherein the first binder component is radiation curable and the second binder component comprises a powder and is thermally curable.
Patent IL-183455-A0 (IL)
Title: A method of computing a hologram
Filed: 2007-05-28
Abstract: A method of computing a hologram by determining the wavefronts at the approximate observer eye (OE) position that would be generated by a real version of an object to be reconstructed. In normal computer generated holograms, one determines the wavefronts needed to reconstruct an object; this is not done directly in the present invention. Instead, one determines the wavefronts at an observer window (OW) that would be generated by a real object located at the same position of the reconstructed object (3D-S). One can then back-transform these wavefronts to the hologram to determine how the hologram needs to be encoded to generate these wavefronts. A suitably encoded hologram (HA) can then generate a reconstruction of the three-dimensional scene (3D-S) that can be observed by placing one's eyes at the plane (OP) of the observer window (OW) and looking through the observer window (OW).
Patent IL-189457-A0 (IL)
Title: Pancreatin micropellet cores suitable for enteric coating
Filed: 2008-02-12
Abstract: Described herein are a process for manufacturing and using pancreatin micropellet cores and pancreatin micropellet cores obtainable according to that process which are substantially free of synthetic oils. Further described are enteric coated pancreatin mi¬ cropellets. In one embodiment, a pharmaceutical composition is provided comprising a pancreatin micropellet with an enteric coating being designed to deliver pancreatin to the upper portion of the intestine of a mammal for release.
Patent IL-202814-A0 (IL)
Title: Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
Filed: 2009-12-17
Abstract: The invention relates to compounds of the formula R1 is selected from the group consisting of hydrogen, linear C1-C3 alkyl and fluorinated linear C1-C3 alkyl; R2 is hydrogen or methyl; R3 is selected from the group consisting of hydrogen, halogen, C1-C2-alkyl, fluorinated C1-C2-alkyl, C1-C2-alkoxy and fluorinated C1-C2-alkoxy, R4 is C1-C2-alkyl or fluorinated C1-C2-alkyl; n is 0, 1 or 2, and the physiologically tolerated salts of these compounds and the N-oxides thereof. The invention also relates to a pharmaceutical composition that comprises at least one compound of the formula I and/or at least one physiologically tolerated acid addition salt thereof, and further to a method for treating disorders that respond beneficially to dopamine D3 receptor antagonists or dopamine D3 agonists, said method comprising administering an effective amount of at least one compound or physiologically tolerated acid addition salt of the formula I to a subject in need thereof.
Patent RO-125713-A0 (RO)
Title: Biocomposite material and process for obtaining the same
Inventor: GINGU OANA
IPC: C08L33/02
Filed: 2010-04-09
Abstract: The invention relates to a biocomposite material with ceramic matrix reinforced with metallic particles, usable in grafting bone tissues and to a process for obtaining the same. According to the invention, the material is obtained by sintering a quantity of 50...85% parts by weight, of nanometric hydroxyapatite grains with the granulation ranging between 300...600 nm and 50...15% parts by weight of micronic crystalline Ti grains with the granulation ranging between 5...90 μ m, the material having a density of 1.9...2.5 g/cm, a porosity of 5...12%, a friction coefficient ranging between 0.5...0.7 and a wear rate ranging between 0.9...1.8x10 mm/Nm. According to the invention, the process consists in roasting the hydroxyapatite powder with the granulation of 100...400 nm, for 0.5...3 hours at a temperature ranging between 800...1000°C, followed by dosing and homogenizing the mixture of roasted hydroxyapatite powders with Ti powder with granulation of 50...30 μm in the presence of a solvent, drying in the air the powder mixture inside an electric oven for 10...24 hours at a temperature ranging between 100...300°C, disintegrating the powder mixture conglomerates by milling in a planetary mill for 1...10 minutes, followed by compacting the powder mixture, with a pressure of 5...50 kN, simultaneously with sintering with plasma discharge thereof, in an inert medium, within the temperature interval ranging between 800...1200°C, for 5...60 minutes.
Patent RO-129677-A0 (RO)
Title: Method for immunobiological assay of chicken immunoglobulins () specific activity
Inventor: PĂTRAŞCU IONEL VICTOR
IPC: G01N33/53
Filed: 2014-03-05
Abstract: The invention relates to a method for immunologically assessing the activity of poultry immunoglobulin IgY. According to the invention, the method consists in using a standard assessment kit in accordance with the working protocol for highlighting the capacity of inhibiting the in-vitro bacterial multiplication by the antigen-specific IgY, the results being then spectrophotometrically viewed.